1. MARK L LOUP
121 ScarlettLane| 504-881-3916| lebro7@att.net
PROFESSIONAL SUMMARY
Results-driven SalesProfessional andManager with expertiseinlead qualificationsand
closingstrategies.Extensivesales trainingand presentation skills with over 17yearsin
salesand5 in salesmanagement. Aproven record of salesachievements,experience,
and recognition inthepharmaceutical,medical and construction industries.Extensive
experiencecallingon and sellingto physiciansrangingfromprimarycareto specialists
includinginternists,orthopedicsurgeons,urological surgeons,cardiologists,
pulmonologists,nephrologists,painmanagementand emergency medicine. Sales
resultsinclude:
 PresidentsClub AwardWinnerin 2006and ranked #8 in theU.S.
 Launched Buy and Bill TrelstarIMinjectionin 2005-06andheld top
15 rankingduringall sellingquarters
 DistrictSalesTrainer forSoutheastRegionin 2002-03
 Exceeded salesgoalsevery quarter in2011, 2012and 2013by a range
of 101%to as much as 118%of quota.
 Successfullylaunched residential buildinganddemolitioncampaigns
in the mostdevastated areasof NewOrleans, Louisianafollowingthe
events of HurricaneKatrina
Established asuccessful record of performancewith physician in-services,discussing
managed-careformulary issues,launchingnewproducts,and buildinga strongnetwork
of specialty physicians,nurses,and medical professionals.
WORK HISTORY
11/2011to
current
Senior Specialty Professional SalesRepresentative, ActavisPharmaceuticals
 Currently servingasa Cardiology,Urology,andPulmonology Specialty Representative
sellingBystolic(hypertension medication),Tudorza(COPD treatment),Daliresp (COPD
treatment),Androgel 1.62%(testosteronetherapyreplacement),and Rapaflo (BPH
treatment) to Urologists,Endocrinologists,andPrimaryCare physiciansin theNew
Orleansand South LouisianaTerritories.Previously sold Enablex (overactivebladder
treatment) and Androderm(testosteronetherapy replacement).
Turned around anunderperformingterritoryin 2012thatwas#153 outof #154 usinga
clinical-based sales approach targetingtop prescribingphysiciansandsuccessfully
exceeded expectationsevery quarter in 2012,2013 and 2014.
Finished Q4 2013ranked #15 intheU.S. at115%to goal for Rapaflo.
Continued to accelerateprescription growthduring2014with Q1-Q4 rankingintop
25%for Rapaflo.Inherited an underperformingCOPD and CardiovascularMarketin Q4
2014 thatwas #146outof #148 and within 4 month moved 68 spotsto finish YTD 2014
#78.

2. Page2
Applied an extensiveknowledgeof pharmacybenefitsandmanaged careformulary
opportunitieswhen discussing insurancecoverageandbenefit plansfor each
medication with thephysiciansand medical staff.
06/2008to
11/2011
Sales Manager,Construction Containerand Demolition Services,IESICorporation of
Louisiana
Managed teamwhoseresponsibilitiesincluded construction roll off and demolition
sales.Responsibilitiesincluded scheduling,field ride-alongs,accounting,customer
management,and budgetmanagement
Negotiated commercial and governmental contracts ,bid packageandRFP’s which
exceeded over $50,000 USD
Sold over $1.1 millionin newdemolition contactsduringcalendar year 2009-2010
Increased Demolition andRoll OffContainer Salesby over $1.9 million by
November,2011
01/2007to
05/2008
Residentialand CommercialConstruction SalesManager,
Ray Leach Construction Inc.
Managed teamresponsiblefor sales,bid proposals,contactnegotiations,customer
relationsandwarranty work.Supervised andassisted in developingsales leadsand
referral business
Successfullylaunched residential buildingcampaign in devastated areasof New
Orleans,LAfollowingtheevents of HurricaneKatrinainAugust2005
Exceeded new home salesgoalsfor calendaryear 2007, 2008.Sold$2.8 million in 2007
and $5.2 in 2008
09/2003to
01/2007
SpecialtySales Representative,Watson Pharmaceuticals
Launched TrelstarIMInjection for thetreatmentof prostatecancer
Top 15 nationally ranked during2005launch of Trelstar
Exceeded quarterly goalsfor OxyTrol TDS Patch (incontinencetreatment),Androderm
TDS (testosteronetreatment) Patch and Reprexan(paintreatment) duringcalendar
years 2004,2005,2006
10/2001to
09/2003
SpecialtySales Representative,ProfessionalDetailingInc./ Abbott Laboratories
Exceeded quarterly goalsfor Oxycontin (pain treatment) calendaryear 2002
Top 20%nationally for Oxycontin (pain treatment) calendaryear 2002
DistrictTrainer forSoutheastRegional Team
EDUCATION
1996 Graduate:Bachelorof Arts ,Southeastern LouisianaUniversity

3. Page3